Table 4. Postoperative outcomes (propensity-matched).

Study	Year	Approach	n	CVA [%]	AF [%]	PPM [%]	AI [%]	AKI [%]	Major Bleeding [%]	Sternotomy [%]	Mortality [%]
RT
Terwelp	2017	MiAVR	115	0 [0.0]	30 [26]	NR	NR	NR	4 [4]	NR	3 [3]
		TAVI-TA	115	1 [0.9]	24 [21]	NR	NR	NR	1 [1]	NR	1 [1]
Terwelp	2017	MiAVR	247	1 [0.4]	48 [20]	NR	NR	NR	3 [1]	NR	2 [1]
		TAVI-TF	247	9 [3.6]	9 [4]	NR	NR	NR	2 [1]	NR	2 [1]
Micelli	2016	MiAVR	37	4 [2.2]	NR	2	0	3 [2]	7 [4]	2 [1]	1 [1]
		TAVI	37	3 [3.3]	NR	0	10	2 [2]	3 [3]	3 [3]	8 [9]
HS
Furukawa	2018	MiAVR	177	2 [1.1]	43 [24]	10	1	21 [12]	3 [2]	NR	4 [2]
		TAVI-TA	177	1 [0.7]	24 [14]	24	3	17 [10]	5 [3]	NR	8 [5]
		TAVI-TF	177	2 [1.1]	11 [6]	34	23	2 [1]	6 [3]	NR	3 [2]
Calle-Verda	2018	MiAVR	50	1 [2.0]	1 [2]	2	0	NR	0	1 [2]	1 [2]
		TAVI	50	2 [4.0]	11 [22]	15	8	NR	0	0	0
Zierer	2009	MiAVR	30	1 [3.3]	3 [10]	0	0	3 [10]	1 [3.3]	0	3 [10]
		TAVI	21	0 [0.0]	0	1	5	0	2 [9.5]	2 [10]	3 [14]
COM
Paparella	2019	MiAVR	348	3 [0.9]	123 [35]	10	NR	56 [16]	12 [4]	NR	13 [4]
		TAVI	348	1 [<0.1]	9 [3]	75	NR	15 [4]	3 [1]	NR	9 [3]

Continuous data presented as mean ± SD. RT, right anterior thoracotomy; HS, hemi-sternotomy; COM, combined; NR, not reported; CVA, cerebrovascular accident; AF, atrial fibrillation; PPM, permanent pacemaker; AI, aortic insufficiency; AKI, acute kidney injury; MiAVR, minimally invasive aortic valve replacement; TAVI, transcatheter aortic valve implantation; TAVI-TF, transfemoral TAVI; TAVI-TA, transapical TAVI.